Remifentanil 2 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F21SK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,082
Award facts
- Contract value 100% obligated
- $7,081.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,081.55 to supply Remifentanil 2 mg vials, with an ultimate completion date of February 3, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract valued at up to $999,999,999.00 with DLA Troop Support Medical extending through December 31, 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, operating under its parent Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs. The company's extensive portfolio with the DLA includes delivery of a broad spectrum of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This particular delivery order for Remifentanil—an opioid analgesic commonly used in medical anesthesia and critical care settings—represents one of numerous task orders fulfilling the company's comprehensive supply obligations to support military treatment facilities and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F21SK?
SPE2DR26F21SK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26F21SK worth?
The government has obligated $7,082 on SPE2DR26F21SK.
Is contract SPE2DR26F21SK an order under another contract?
Yes. SPE2DR26F21SK is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21SK competed?
The extent of competition for SPE2DR26F21SK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award